Stryker (NYSE:SYK) said yesterday that CFO and veep William Jellison is retiring, and will be replaced by former medsurg & neurotechnology group CFO Glenn Boehnlein. The Kalamazoo, Mich.-based company said Jellison, who’s been with Styker for 3 years, will pursue positions on boards and devote more time to his family. Jellison will stay on through […]
Hospira Inc.
Report: Pfizer mulls sale of Hospira infusion pump biz
Pfizer (NYSE:PFE) is reportedly mulling a sale of the infusion pump business it acquired along with Hospira last year, aiming to focus on its core branded pharmaceuticals business. Hospira makes generic versions of injectable drugs used in hospitals, pumps to deliver them and also sells biosimilars or copies of biotech drugs. New York City-based Pfizer closed the $15 […]
US Senators urge FTC to probe Baxter, Braun & Hospira saline prices
Four U.S. Senators yesterday wrote the FTC urging a probe into possible illegal saline price inflation of 200-300% since a shortage of the fluid began in late 2013. The letter, sent to FTC chairwoman Edith Ramirez, was signed by Conn. dem senator Richard Blumenthal, Minn. dem Amy Klobuchar and Utah reps. Mike Lee and Orrin […]
Pfizer closes $15B Hospira takeover
Pfizer (NYSE:PFE) yesterday closed its $15 billion acquisition of Hospira, its largest-ever buyout, expanding its portfolio of generic injectable drugs and copies of biotech medicines. Hospira makes generic versions of injectable drugs used in hospitals, pumps to deliver such medicine and also sells biosimilars or copies of biotech drugs. Pfizer paid $90 per share in cash, a 39% […]
Hospira, Philips win Defense Dept. contracts worth $68m
The Department of Defense said yesterday that Hospira (NYSE:HSP) and Royal Philips (NYSE:PHG) won contracts with the defense agency for $50 million and $18.8 million, respectively. Hospira won a contract with the Defense Logistics Agency for $50 million to supply the department with pharmaceutical products, the DoD said. Hospira topped 35 other companies vying for the competitive […]
FTC clears Pfizer’s $15B Hospira buy
Pfizer (NYSE:PFE) said Monday it won approval from the Federal Trade Commission for its $15 billion acquisition of Hospira (NYSE:HSP). The clearance came with a caveat –Pfizer must divest itself of its Acetylcysteine, Clindamycin, Voriconazole and Melphalan sterile injectable assets, according to the company. The news from the FTC came August 21, according to an SEC filing from […]
Pfizer wins Canadian approval for $15B Hospira buy
Pfizer (NYSE:PFE) said it won approval from the Canadian Competition Bureau for its $15 billion acquisition of Hospira (NYSE:HSP). As part of the agreement, the healthcare and pharmaceutical giant said it committed to divesting certain assets of the company in Canada, according to a press release. “We are pleased the Canadian Competition Bureau concluded its review […]
FDA warns that Hospira Symbiq pumps can be hacked
The FDA today released a safety communication warning about cybersecurity vulnerabilities with Hospira’s (NYSE:HSP) Symbiq infusion system. The Symbiq infusion system can potentially be accessed remotely through a hospital’s network, which could allow for unauthorized changes to the dosage delivered by the pump, according to the federal watchdog. The issue was confirmed by Hospira and […]
Pfizer offers concessions to win EU okay for Hospira deal
(Reuters) — Pfizer (NYSE:PFE) offered concessions in a bid to win European Union regulatory approval for its $15 billion takeover of U.S. rival Hospira (NYSE:HSP), the European Commission said today. The EU competition authority did not provide details of Pfizer’s proposal, in line with its policy. It extended the deadline for its decision to Aug. 4 […]